Startup | October 01, 2025
DPIIT and Thermo Fisher Scientific launch BioVerse challenge to fast-track India’s biotech future
India currently hosts more than 10,075 biotech startups
India currently hosts more than 10,075 biotech startups
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
Advent acquired Zentiva from Sanofi in 2018 and transformed the company into a highly successful standalone business
Four FDA-approved products strengthen portfolio and reaffirm commitment to global reach
New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
RTX001 represents a groundbreaking advance in the treatment of end-stage liver disease, offering new hope for patients with limited options
Free cash flow also reached €63 million, representing an 11 percent increase compared to the high benchmark set in 2024
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
The company’s virgin PET chips plant in Egypt, commissioned in Q4 FY25, achieved 74.8 per cent capacity utilization in its first full quarter. In India, the Panipat facility operated at 96.6 per cent utilization
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
Subscribe To Our Newsletter & Stay Updated
